Quantifying cardiovascular disease risk factors in patients with psoriasis: A meta-analysis

British Journal of Dermatology

Volumn 169, Issue 6, 2013, Pages 1180-1187

  Miller, I M ^a   Skaaby, T ^c   Ellervik, C ^b,d   Jemec, G B E ^a,b  

^a ROSKILDE HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d NAESTVED HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ABDOMINAL FAT; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; HUMAN; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; COMPLICATION; GLUCOSE BLOOD LEVEL; META ANALYSIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; OBSERVATIONAL STUDY AS TOPIC; PSORIASIS; RISK FACTORS;

EID: 84889062964     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12490     Document Type: Review

References (32)

1. Miller IM, Ellervik C, Yazdanyar S, Jemec G,. Meta-analysis of psoriasis and cardiovascular disease and associated risk factors. J Am Acad Dermatol 2013 (in press).
2. Troitzsch P, Markus MRP, Dörr M, et al,. Psoriasis is associated with increased intima-media thickness-the Study of Health in Pomerania (SHIP). Atherosclerosis 2012; 225: 486-90.
3. Ahlehoff O, Skov L, Gislason G, et al,. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med 2013; 273: 197-204.
4. Bang CN, Okin PM, Køber L, et al,. Psoriasis is associated with subsequent atrial fibrillation in hypertensive patients-the LIFE Study. Int J Cardiol 2013 (in press).
5. Ahlehoff O, Gislason GH, Charlot M, et al,. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011; 270: 147-57.
6. Mehta NN, Azfar RS, Shin DB, et al,. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010; 31: 1000-6.
7. Gisondi P, Girolomoni G,. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 2009; 35: 313-24.
8. Miller IM, Jemec G,. Maturation of an idea: a historical perspective on the association of psoriasis with the metabolic syndrome and cardiovascular disease. Arch Dermatol 2012; 148: 112.
9. Stroup DF, Berlin JA, Morton SC, et al,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
10. Diabetes UK and The Association for Clinical Biochemistry. HbA1c Standardisation for Laboratory Professionals. London: Diabetes UK, 2009.
11. Higgins JPT, Green S,. Cochrane Handbook for Systematic Reviews of Interventions. Available at: http://www.cochrane.org/training/cochrane-handbook (last accessed 11 September 2013).
12. Higgins J, Thompson S, Deeks J, Altman D,. Measuring inconsistency in meta-analysis. Br J Dermatol 2003; 327: 557-60.
13. Egger M, Smith G, Altman D,. Systematic Reviews in Health Care. Meta-analysis in Context, 2nd edn. London: BMJ Books, 2001.
14. Higgins J, Thompson S,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-58.
15. Ridker PM, Danielson E, Fonseca FA, et al,. Rosuvastatin to preventvascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-207.
16. Holzer M, Wolf P, Curcic S, et al,. Psoriasis alters HDL composition and cholesterol efflux capacity. J Lipid Res 2012; 53: 1618-24.
17. Mehta NN, Li R, Krishnamoorthy P, et al,. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis 2012; 224: 218-21.
18. Law MR, Morris JK, Wald NJ,. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
19. Sipahi I, Swaminathan A, Natesan V, et al,. Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials. Stroke 2012; 43: 432-40.
20. Whelton PK, He J, Appel LJ, et al,. Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002; 288: 1882-8.
21. Després JP, Arsenault BJ, Côté M, et al,. Abdominal obesity: the cholesterol of the 21st century? Can J Cardio 2008; 24 (Suppl. D): 7-12D.
22. Tuomilehto J, Lindström J, Eriksson JG, et al,. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
23. Nesto RW, Lago RM,. Glucose: a biomarker in acute myocardial infarction ready for prime time? Circulation 2008; 117: 990-2.
24. Kloner RA, Nesto R,. Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection. Circulation 2008; 117: 2523-33.
25. Hewitt J, Castilla Guerra L, Fernández-Moreno Mdel C, Sierra C,. Diabetes and stroke prevention: a review. Stroke Res Treat 2012; 2012: 673187.
26. Kuusisto J, Laakso M,. Update on type 2 diabetes as a cardiovascular disease risk equivalent. Curr Cardiol Rep 2013; 15: 331.
27. MacIsaac RJ, Jerums G,. Intensive glucose control and cardiovascular outcomes in type 2 diabetes. Heart Lung Circ 2011; 20: 647-54.
28. Sattar N,. Revisiting the links between glycaemia, diabetes and cardiovascular disease. Diabetologia 2013; 56: 686-95.
29. Park C, Guallar E, Linton JA, et al,. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. Diabetes Care 2013; 36: 1988-93.
30. Armesto S, Coto-Segura P, Osuna CG, et al,. Psoriasis and hypertension: a case-control study. J Eur Acad Dermatol Venereol 2012; 26: 785-8.
31. Armstrong AW, Harskamp CT, Armstrong EJ,. Psoriasis and the risk of diabetes mellitus. JAMA Dermatol 2013; 149: 84-91.
32. Xu T, Zhang YH,. Association of psoriasis with stroke and myocardial infarction: a meta-analysis of cohort studies. BJD 2012; 167: 1345-50.